Esther Hian Li Chan
机构:National University of Singapore, Singapore College of Traditional Chinese Medicine, National University Cancer Institute, Singapore, National Cancer Centre Singapore, National University Hospital, National University Health System · ORCID:0000-0003-1006-5601
发表论文 93 篇 · 总被引 875 次 · h-index 10
代表论文
- Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma (2024 · Nature Communications · 被引 47)
- Targeting the DNA damage response in hematological malignancies (2024 · Frontiers in Oncology · 被引 10)
- EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CML (2025 · Leukemia · 被引 6)
- Abstract CT160: A phase I trial to evaluate allogeneic NKG2DL-targeting chimeric antigen receptor-grafted γδ T cells in subjects with advanced solid tumors or hematological malignancies (the ANGELICA Trial) (2024 · Cancer Research · 被引 4)
- Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma (2025 · Blood Cancer Journal · 被引 3)
- Evaluating the Comprehensive Geriatric Assessment Model As an Assessment Tool to Predict Chemotoxicity in Elderly Patients with Lymphoma (2024 · Blood · 被引 2)